Vela Pharmaceuticals Inc. (Lawrence...

Vela Pharmaceuticals Inc. (Lawrenceville, NJ) complet its Phase 2 research of very low dosage cyclobenzaprine. The meditation included 36 subjects suffering from fibromyalgia syndrome and poor be motionless Subjects took a 1-4 mg dose of the medicine before bedtime or placebo for eight weeks. inferences indicate that the mix with drugs reduced musculoskeletal pain and fatigue and improved be dead No serious adverse events were reported.

The consequence s of a Phase 2 clinical trial reported in The Oncologist exhibits that a combination of